News &amp; Updates

Combining high-dose vitamin D supplementation (VDS) with enuresis alarm (EA) therapy results in significant reductions in wet-night frequency and improves treatment response, satisfaction, and quality of life (QoL) relative to EA alone in children with primary monosymptomatic nocturnal enuresis (PMNE) and serum 25-hydroxyvitamin D (25[OH]D) levels below 30 ng/mL, a study has shown.

Vitamin D plus enuresis alarm reduces wet nights, improves QoL in children with PMNE

Study takes a deep dive into mental health help-seeking behaviours in SG’s migrant workforce

A mixed-methods, two-phase study sheds light on help-seeking behaviours and perceived barriers and facilitators to mental health support among migrant workers (MWs) and migrant domestic workers (MDWs) in Singapore.

Study takes a deep dive into mental health help-seeking behaviours in SG’s migrant workforce

Quercetin may help adults with ASD

In adults with autism spectrum disorder (ASD), quercetin supplementation shows signal of benefit, with improvements observed in quality of life and social responsiveness, according to a study.

Quercetin may help adults with ASD

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise

Atherosclerotic cardiovascular disease (ASCVD) affects a substantial proportion of adults with β-thalassaemia. It appears to be driven by conventional CV risk factors rather than disease-specific features, according to research presented at EHA2026.

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise

04 Aug 2026

Izokibep maintains PsA efficacy at 52 weeks

The novel small-protein IL-17 inhibitor izokibep demonstrates durable efficacy and a favourable safety profile over 52 weeks in patients with active psoriatic arthritis (PsA), with sustained improvements in joint, skin, and quality-of-life outcomes in a phase IIB/III study.

Izokibep maintains PsA efficacy at 52 weeks

04 Aug 2026

HK cases: Aflibercept 8 mg achieves rapid disease control with extended treatment intervals in DME

A 54-year-old male with an 8-year history of type 2 diabetes (T2D; HbA_1c, 8 percent) reported blurred vision in the right eye (OD) on 5 June 2023. He was diagnosed with OD diabetic macular oedema (DME) and bilateral (OU) proliferative diabetic retinopathy (PDR).

HK cases: Aflibercept 8 mg achieves rapid disease control with extended treatment intervals in DME

Blood p-Tau217 levels prognostic of cognitive decline risk

A large, multicohort study of cognitively unimpaired older adults has found that higher plasma p-tau217 levels are consistently associated with greater risk of progression to cognitive impairment and faster rates of cognitive decline, providing time-specific absolute risk estimates and supporting the potential of p-tau217 for prognostic model development.

Blood p-Tau217 levels prognostic of cognitive decline risk

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

In the treatment of patients with anti–PD-(L)1–resistant advanced melanoma, response with ceralasertib plus durvalumab is low, according to the phase II MONETTE study.

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

Study warns of adulterated complementary health products

03 Aug 2026 by

Some complementary health products (CHPs), such as health supplements, contain undeclared substances that pose significant health risks, according to a study.

Study warns of adulterated complementary health products

Low FT levels linked to frailty in men with advanced CLD

Low levels of free testosterone (FT) appear to contribute to frailty in male patients with advanced chronic liver disease (CLD), according to a study.

Low FT levels linked to frailty in men with advanced CLD